Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
(Given the potential long-term consequences of NMOSD relapses, the company could not ethically include a direct placebo arm in its Phase III trial.) Ultomiris was well-tolerated overall, and most treatment-emergent events were mild or moderate in severity, according to AstraZeneca
Key characteristics of NAION include: Sudden vision loss, often upon waking Permanent damage with no proven treatment to restore vision Increased risk of vision loss in the other eye Significant impact on quality of life, independence, and ability to work For many patients, the NAION-related optic nerve damage is life-altering and irreversible
June 22, 2005
KLOW Blend Calculator and Educational Peptide Tools GoalBMI Wellness provides educational calculators to help patients understand how prescribed peptide doses, vial concentrations, injection volumes and syringe units relate to one another
Duan M, Leng S, Mao P
